ArticleAntimicrobial agents and chemotherapy1998

Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.

D L Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.